Skip to content
2000
image of Cathepsins in Ischemic Stroke: Unveiling Neuropharmacological Roles and Therapeutic Potential

Abstract

Ischemic stroke is a complex and heterogeneous neurological disorder with high mortality and long-term disability rates, yet effective clinical biomarkers and targeted therapies remain elusive. Despite extensive research, the molecular mechanisms driving ischemic stroke pathophysiology are still not fully understood. Cathepsins, a family of endo/lysosomal proteases, play a crucial role in modulating neuronal protein activation and degradation, thereby exerting both neuroprotective and neurotoxic effects. This review synthesizes current findings on the neuropharmacological roles of cathepsins in ischemic stroke, highlighting their dual functions and potential as therapeutic targets. By providing an integrated perspective, this article aims to uncover novel molecular pathways implicated in stroke progression and identify innovative therapeutic strategies centered on cathepsin modulation. Furthermore, this review explores the potential of cathepsins as biomarkers, paving the way for more precise, personalized interventions that could ultimately improve patient outcomes and mitigate long-term disability in ischemic stroke survivors.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X399036251124052750
2026-01-09
2026-02-27

  • From This Site

    /content/journals/cn/10.2174/011570159X399036251124052750
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Roth G.A. Forouzanfar M.H. Moran A.E. Barber R. Nguyen G. Feigin V.L. Naghavi M. Mensah G.A. Murray C.J.L. Demographic and epidemiologic drivers of global cardiovascular mortality. N. Engl. J. Med. 2015 372 14 1333 1341 10.1056/NEJMoa1406656 25830423
    [Google Scholar]
  2. Chen X. Du Y.M. Xu F. Liu D. Wang Y.L. Propofol prevents hippocampal neuronal loss and memory impairment in cerebral ischemia injury through promoting PTEN degradation. J. Mol. Neurosci. 2016 60 1 63 70 10.1007/s12031‑016‑0791‑y 27480093
    [Google Scholar]
  3. Yang S. Hu B. Wang Z. Zhang C. Jiao H. Mao Z. Wei L. Jia J. Zhao J. Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway. Cell Death Discov. 2020 6 1 102 10.1038/s41420‑020‑00338‑3 33083022
    [Google Scholar]
  4. Feigin V.L. Owolabi M.O. Feigin V.L. Abd-Allah F. Akinyemi R.O. Bhattacharjee N.V. Brainin M. Cao J. Caso V. Dalton B. Davis A. Dempsey R. Duprey J. Feng W. Ford G.A. Gall S. Gandhi D. Good D.C. Hachinski V. Hacke W. Hankey G.J. Ishida M. Johnson W. Kim J. Lavados P. Lindsay P. Mahal A. Martins S. Murray C. Nguyen T.P. Norrving B. Olaiya M.T. Olalusi O.V. Pandian J. Phan H. Platz T. Ranta A. Rehman S. Roth G. Sebastian I.A. Smith A.E. Suwanwela N.C. Sylaja P.N. Thapa R. Thrift A.G. Uvere E. Vollset S.E. Yavagal D. Yaria J. Owolabi M.O. Owolabi M.O. Feigin V.L. Abd-Allah F. Abera S.F. Akinyemi R. Brainin M. Caso V. Dempsey R.J. Ford G.A. Gall S. Gandhi D. Hachinski V. Hacke W. Hankey G.J. Ibrahim N.M. Johnson W. Lavados P. Liu L. Lindsay P. Martins S. Norrving B. Olaiya M.T. Ovbiagele B. Pandian J. Phan H. Piradov M. Platz T. Ranta A. Roth G. Sebastian I.A. Suwanwela N. Sylaja P.N. Thrift A.G. Uvere E. Yaria J. Abanto C. Addissie A. Adeleye A.O. Adilbekov Y. Adilbekova B. Adoukonou T.A. Aguiar de Sousa D. Akhmetzhanova Z. Akpalu A. El Alaoui-Faris M. Ameriso S.F. Andonova S. Arsovska A. Awoniyi F.E. Bakhiet M. Barboza M.A. Basri H. Bath P.M. Bereczki D. Beretta S. Berkowitz A.L. Bernhardt J. Berzina G. Bhavsar B. Bisharyan M.S. Bohara M. Bovet P. Budincevic H. Cadilhac D.A. Čerimagić D. Charway-Felli A. Chen C. Chin J.H. Christensen H. Chwojnicki K. Conforto A.B. Correia M. Mora Cuervo D.L. Członkowska A. D’Amelio M. Danielyan K.E. Davis S. Demarin V. Demchuk A.M. Dichgans M. Dokova K. Donnan G. Duran J.C. Ekeng G. Elkind M.S. Endres M. Fischer U. Flomin Y. Gankpe F. Gavidia M. Gaye Saavedra A. Gebreyohanns M. George M. Gierlotka M. Giroud M. Gnedovskaya E.V. Gonçalves I.P. Gongora-Rivera F. Gunaratne P.S. Hamadeh R.R. Hamzat T.K. Heldner M.R. Ibrahim E. Ihle-Hansen H. Jee S. Jiann-Shing J. Johnston S.C. Jovanovic D. Jurjāns K. Kalani R. Kalkonde Y. Kamenova S. Karaszewski B. Kelly P. Kiechl S. Kondybayeva A. Kõrv J. Kozera G. Kravchenko M. Krespi Y. Krishnamurthi R. Kruja J. Kutluk K. Langhorne P. Law Z.K. Lebedynets D. Lee T-H. Leung T.W. Liebeskind D.S. López-Jaramillo P. Lotufo P.A. Machline-Carrion M.J. Maia L.F. Malojcic B. Markus H.S. Marquez-Romero J.M. Medina M.T. Medukhanova S. Mehndiratta M.M. Miglāne E. Mihejeva I. Mikulik R. Mirrakhimov E. Mohl S. Munakomi S. Murphy S. Musa K.I. Nasreldein A. Nogueira R.G. Nolte C.H. Noubiap J.J. Novarro-Escudero N. Ocampo C. O’Donnell M. Ogun Y. Ogunniyi A. Oraby M.I. Ōrken D.N. Ōzdemir A.O. Ozturk S. Paccot M. Pereira T. Peeters A. Potpara T. Proios H. Rathore F.A. Sacco R.L. Sahathevan R. Sandset E.S. Renato Santos I. Saposnik G. Sarfo F.S. Sargento-Freitas J. Sharma M. Shaw L. Sheth K.N. Shin Y-I. Shobhana A. Silva S.N. Tedim Cruz V. Thakur K. Thapa L.J. Toni D. Topcuoglu M.A. Torales J. Towfighi A. Truelsen T. Tsiskaridze A. Tulloch-Reid M. Useche J.N. Vanacker P. Vassilopoulou S. Vukorepa G. Vuletic V. Wahab K.W. Wang W. Wijeratne T. Wojtyniak B. Wolfe C. Yacouba M.N. Yang J. Yifru Y.M. Yock-Corrales A. Yonemoto N. Yperzeele L. Zagożdżon P. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission. Lancet Neurol. 2023 22 12 1160 1206 10.1016/S1474‑4422(23)00277‑6 37827183
    [Google Scholar]
  5. Jiang C.T. Wu W.F. Deng Y.H. Ge J.W. Modulators of microglia activation and polarization in ischemic stroke (Review). Mol. Med. Rep. 2020 21 5 2006 2018 10.3892/mmr.2020.11003 32323760
    [Google Scholar]
  6. Martin S.S. Aday A.W. Allen N.B. Almarzooq Z.I. Anderson C.A.M. Arora P. Avery C.L. Baker-Smith C.M. Bansal N. Beaton A.Z. Commodore-Mensah Y. Currie M.E. Elkind M.S.V. Fan W. Generoso G. Gibbs B.B. Heard D.G. Hiremath S. Johansen M.C. Kazi D.S. Ko D. Leppert M.H. Magnani J.W. Michos E.D. Mussolino M.E. Parikh N.I. Perman S.M. Rezk-Hanna M. Roth G.A. Shah N.S. Springer M.V. St-Onge M.P. Thacker E.L. Urbut S.M. Van Spall H.G.C. Voeks J.H. Whelton S.P. Wong N.D. Wong S.S. Yaffe K. Palaniappan L.P. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 heart disease and stroke statistics: A report of US and global data from the american heart association. Circulation 2025 151 8 e41 e660 10.1161/CIR.0000000000001303 39866113
    [Google Scholar]
  7. Henninger N. Fisher M. Extending the time window for endovascular and pharmacological reperfusion. Transl. Stroke Res. 2016 7 4 284 293 10.1007/s12975‑015‑0444‑4 26739964
    [Google Scholar]
  8. Dennemärker J. Lohmüller T. Müller S. Aguilar S.V. Tobin D.J. Peters C. Reinheckel T. Impaired turnover of autophagolysosomes in cathepsin L deficiency. Biol. Chem. 2010 391 8 913 922 10.1515/bc.2010.097 20536383
    [Google Scholar]
  9. Vasiljeva O. Reinheckel T. Peters C. Turk D. Turk V. Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 2007 13 4 387 403 10.2174/138161207780162962 17311556
    [Google Scholar]
  10. Bird P.I. Trapani J.A. Villadangos J.A. Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol. 2009 9 12 871 882 10.1038/nri2671 19935806
    [Google Scholar]
  11. Liu Y. Xue X. Zhang H. Che X. Luo J. Wang P. Xu J. Xing Z. Yuan L. Liu Y. Fu X. Su D. Sun S. Zhang H. Wu C. Yang J. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia. Autophagy 2019 15 3 493 509 10.1080/15548627.2018.1531196 30304977
    [Google Scholar]
  12. Kilinc M. Gürsoy-Özdemir Y. Gürer G. Erdener S.E. Erdemli E. Can A. Dalkara T. Lysosomal rupture, necroapoptotic interactions and potential crosstalk between cysteine proteases in neurons shortly after focal ischemia. Neurobiol. Dis. 2010 40 1 293 302 10.1016/j.nbd.2010.06.003 20600913
    [Google Scholar]
  13. Hossain M.I. Marcus J.M. Lee J.H. Garcia P.L. Singh V. Shacka J.J. Zhang J. Gropen T.I. Falany C.N. Andrabi S.A. Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective. Autophagy 2021 17 6 1330 1348 10.1080/15548627.2020.1761219 32450052
    [Google Scholar]
  14. Zhang Q. Zhang N. Kang L. Hu G. Yan X. Ding X. Fu Q. Zhang Y. Zhao N. Gao J. Strangman G.E. Technology development for simultaneous wearable monitoring of cerebral hemodynamics and blood pressure. IEEE J. Biomed. Health Inform. 2019 23 5 1952 1963 10.1109/JBHI.2018.2876087 30334773
    [Google Scholar]
  15. Zhang Q.Y. Wang Z.J. Sun D.M. Wang Y. Xu P. Wu W.J. Liu X.H. Zhu Y.Z. Novel therapeutic effects of leonurine on ischemic stroke: New mechanisms of BBB integrity. Oxid. Med. Cell. Longev. 2017 2017 1 7150376 10.1155/2017/7150376 28690765
    [Google Scholar]
  16. Broderick J. Connolly S. Feldmann E. Hanley D. Kase C. Krieger D. Mayberg M. Morgenstern L. Ogilvy C.S. Vespa P. Zuccarello M. American Heart Association/American Stroke Association Stroke CouncilAmerican Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007 116 16 e391 e413 10.1161/CIRCULATIONAHA.107.183689 17938297
    [Google Scholar]
  17. Feigin V.L. Lawes C.M.M. Bennett D.A. Anderson C.S. Stroke epidemiology: A review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003 2 1 43 53 10.1016/S1474‑4422(03)00266‑7 12849300
    [Google Scholar]
  18. Solanki D. Lahiri U. Design of instrumented shoes for gait characterization: A usability study with healthy and post-stroke hemiplegic individuals. Front. Neurosci. 2018 12 459 10.3389/fnins.2018.00459 30079008
    [Google Scholar]
  19. Mijajlović M.D. Pavlović A. Brainin M. Heiss W.D. Quinn T.J. Ihle-Hansen H.B. Hermann D.M. Assayag E.B. Richard E. Thiel A. Kliper E. Shin Y.I. Kim Y.H. Choi S. Jung S. Lee Y.B. Sinanović O. Levine D.A. Schlesinger I. Mead G. Milošević V. Leys D. Hagberg G. Ursin M.H. Teuschl Y. Prokopenko S. Mozheyko E. Bezdenezhnykh A. Matz K. Aleksić V. Muresanu D. Korczyn A.D. Bornstein N.M. Post-stroke dementia – A comprehensive review. BMC Med. 2017 15 1 11 10.1186/s12916‑017‑0779‑7 28095900
    [Google Scholar]
  20. Lv J. Hu W. Yang Z. Li T. Jiang S. Ma Z. Chen F. Yang Y. Focusing on claudin-5: A promising candidate in the regulation of bbb to treat ischemic stroke. Prog. Neurobiol. 2018 161 79 96 10.1016/j.pneurobio.2017.12.001 29217457
    [Google Scholar]
  21. George P.M. Steinberg G.K. Novel stroke therapeutics: Unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 2015 87 2 297 309 10.1016/j.neuron.2015.05.041 26182415
    [Google Scholar]
  22. Westbroek W. Nguyen M. Siebert M. Lindstrom T. Burnett R.A. Aflaki E. Jung O. Tamargo R. Rodriguez-Gil J.L. Acosta W. Hendrix A. Behre B. Tayebi N. Fujiwara H. Sidhu R. Renvoise B. Ginns E.I. Dutra A. Pak E. Cramer C. Ory D.S. Pavan W.J. Sidransky E. A new glucocerebrosidase deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for gaucher disease. Dis. Model Mech. 2016 9 7 dmm.024588 10.1242/dmm.024588 27482815
    [Google Scholar]
  23. Cinelli M.A. Li H. Pensa A.V. Kang S. Roman L.J. Martásek P. Poulos T.L. Silverman R.B. Phenyl ether- and aniline-containing 2-aminoquinolines as potent and selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 2015 58 21 8694 8712 10.1021/acs.jmedchem.5b01330 26469213
    [Google Scholar]
  24. Kaplan-Arabaci O. Acari A. Ciftci P. Gozuacik D. Glutamate scavenging as a neuroreparative strategy in ischemic stroke. Front. Pharmacol. 2022 13 866738 10.3389/fphar.2022.866738 35401202
    [Google Scholar]
  25. Chen Y.C. Ma N.X. Pei Z.F. Wu Z. Do-Monte F.H. Keefe S. Yellin E. Chen M.S. Yin J.C. Lee G. Minier-Toribio A. Hu Y. Bai Y.T. Lee K. Quirk G.J. Chen G. NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Mol. Ther. 2020 28 1 217 234 10.1016/j.ymthe.2019.09.003 31551137
    [Google Scholar]
  26. McCullough L.D. Mirza M.A. Xu Y. Bentivegna K. Steffens E.B. Ritzel R. Liu F. Stroke sensitivity in the aged: Sex chromosome complement vs. gonadal hormones. Aging 2016 8 7 1432 1441 10.18632/aging.100997 27405096
    [Google Scholar]
  27. Zhang S. Jiang X. Wang Y. Lin K. Zhang Z. Zhang Z. Zhu P. Ng M.L. Qu S. Sze S.C.W. Yung K.K.L. Protective effect of An-Gong-Niu-Huang Wan pre-treatment against experimental cerebral ischemia injury via regulating GSK-3β/HO-1 pathway. Front. Pharmacol. 2021 12 640297 10.3389/fphar.2021.640297 33935731
    [Google Scholar]
  28. Telianidis J. Hung Y.H. Materia S. Fontaine S.L. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front. Aging Neurosci. 2013 5 44 10.3389/fnagi.2013.00044 23986700
    [Google Scholar]
  29. Khanna S. Briggs Z. Rink C. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke. Antioxid. Redox Signal. 2015 22 2 175 186 10.1089/ars.2014.6106 25343301
    [Google Scholar]
  30. Wang X. Tian S. Wang H. Liu P. Zheng H. Wu L. Liu Q. Wu W. Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23. Cell Biosci. 2020 10 1 141 10.1186/s13578‑020‑00501‑4 33298171
    [Google Scholar]
  31. Pelvig D.P. Pakkenberg H. Stark A.K. Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging 2008 29 11 1754 1762 10.1016/j.neurobiolaging.2007.04.013 17544173
    [Google Scholar]
  32. Morioka T. Kalehua A.N. Streit W.J. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 1993 327 1 123 132 10.1002/cne.903270110 8432904
    [Google Scholar]
  33. Hu X. Li P. Guo Y. Wang H. Leak R.K. Chen S. Gao Y. Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012 43 11 3063 3070 10.1161/STROKEAHA.112.659656 22933588
    [Google Scholar]
  34. Hanisch U.K. Kettenmann H. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007 10 11 1387 1394 10.1038/nn1997 17965659
    [Google Scholar]
  35. Dabrowska S. Andrzejewska A. Lukomska B. Janowski M. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J. Neuroinflammation 2019 16 1 178 10.1186/s12974‑019‑1571‑8 31514749
    [Google Scholar]
  36. Jha M.K. Kim J.H. Song G.J. Lee W.H. Lee I.K. Lee H.W. An S.S.A. Kim S. Suk K. Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases. Prog. Neurobiol. 2018 162 37 69 10.1016/j.pneurobio.2017.12.003 29247683
    [Google Scholar]
  37. Hol E.M. Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell Biol. 2015 32 121 130 10.1016/j.ceb.2015.02.004 25726916
    [Google Scholar]
  38. Xu H. You M. Xiang X. Zhao J. Yuan P. Chu L. Xie C. Molecular mechanism of epimedium extract against ischemic stroke based on network pharmacology and experimental validation. Oxid. Med. Cell. Longev. 2022 2022 1 3858314 10.1155/2022/3858314 36338345
    [Google Scholar]
  39. Qiu Y. Zhang C. Chen A. Wang H. Zhou Y. Li Y. Hu B. Immune cells in the BBB disruption after acute ischemic stroke: Targets for immune therapy? Front. Immunol. 2021 12 678744 10.3389/fimmu.2021.678744 34248961
    [Google Scholar]
  40. Gan Y. Liu Q. Wu W. Yin J.X. Bai X.F. Shen R. Wang Y. Chen J. La Cava A. Poursine-Laurent J. Yokoyama W. Shi F.D. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc. Natl. Acad. Sci. USA 2014 111 7 2704 2709 10.1073/pnas.1315943111 24550298
    [Google Scholar]
  41. Chamorro Á. Meisel A. Planas A.M. Urra X. van de Beek D. Veltkamp R. The immunology of acute stroke. Nat. Rev. Neurol. 2012 8 7 401 410 10.1038/nrneurol.2012.98 22664787
    [Google Scholar]
  42. Kang L. Yu H. Yang X. Zhu Y. Bai X. Wang R. Cao Y. Xu H. Luo H. Lu L. Shi M.J. Tian Y. Fan W. Zhao B.Q. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat. Commun. 2020 11 1 2488 10.1038/s41467‑020‑16191‑y 32427863
    [Google Scholar]
  43. Cai W. Liu S. Hu M. Huang F. Zhu Q. Qiu W. Hu X. Colello J. Zheng S.G. Lu Z. Functional dynamics of neutrophils after ischemic stroke. Transl. Stroke Res. 2020 11 1 108 121 10.1007/s12975‑019‑00694‑y 30847778
    [Google Scholar]
  44. Hu X. Leak R.K. Shi Y. Suenaga J. Gao Y. Zheng P. Chen J. Microglial and macrophage polarization—new prospects for brain repair. Nat. Rev. Neurol. 2015 11 1 56 64 10.1038/nrneurol.2014.207 25385337
    [Google Scholar]
  45. Zhang Y. Gao Z. Wang D. Zhang T. Sun B. Mu L. Wang J. Liu Y. Kong Q. Liu X. Zhang Y. Zhang H. He J. Li H. Wang G. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10. J. Neuroinflammation 2014 11 1 79 10.1186/1742‑2094‑11‑79 24742325
    [Google Scholar]
  46. Vivier E. Tomasello E. Baratin M. Walzer T. Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008 9 5 503 510 10.1038/ni1582 18425107
    [Google Scholar]
  47. Mindell J.A. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 2012 74 1 69 86 10.1146/annurev‑physiol‑012110‑142317 22335796
    [Google Scholar]
  48. Zhang Z. Yue P. Lu T. Wang Y. Wei Y. Wei X. Role of lysosomes in physiological activities, diseases, and therapy. J. Hematol. Oncol. 2021 14 1 79 10.1186/s13045‑021‑01087‑1 33990205
    [Google Scholar]
  49. Zhang X. Wei M. Fan J. Yan W. Zha X. Song H. Wan R. Yin Y. Wang W. Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons. Autophagy 2021 17 6 1519 1542 10.1080/15548627.2020.1840796 33111641
    [Google Scholar]
  50. Colacurcio D.J. Nixon R.A. Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev. 2016 32 75 88 10.1016/j.arr.2016.05.004 27197071
    [Google Scholar]
  51. Maxfield F.R. Role of endosomes and lysosomes in human disease. Cold Spring Harb. Perspect. Biol. 2014 6 5 a016931 10.1101/cshperspect.a016931 24789821
    [Google Scholar]
  52. Luzio J.P. Pryor P.R. Bright N.A. Lysosomes: Fusion and function. Nat. Rev. Mol. Cell Biol. 2007 8 8 622 632 10.1038/nrm2217 17637737
    [Google Scholar]
  53. Engin A. Engin A.B. N-Methyl-D-Aspartate receptor signaling-protein kinases crosstalk in cerebral ischemia. Adv. Exp. Med. Biol. 2021 1275 259 283 10.1007/978‑3‑030‑49844‑3_10 33539019
    [Google Scholar]
  54. Liu Y. Che X. Zhang H. Fu X. Yao Y. Luo J. Yang Y. Cai R. Yu X. Yang J. Zhou M.S. CAPN1 (Calpain1)-mediated impairment of autophagic flux contributes to cerebral ischemia-induced neuronal damage. Stroke 2021 52 5 1809 1821 10.1161/STROKEAHA.120.032749 33874744
    [Google Scholar]
  55. Sahara S. Yamashima T. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem. Biophys. Res. Commun. 2010 393 4 806 811 10.1016/j.bbrc.2010.02.087 20171158
    [Google Scholar]
  56. Windelborn J.A. Lipton P. Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA‐mediated calcium influx, arachidonic acid metabolism, and free radical production. J. Neurochem. 2008 106 1 56 69 10.1111/j.1471‑4159.2008.05349.x 18363826
    [Google Scholar]
  57. Muralikrishna Adibhatla R. Hatcher J.F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 2006 40 3 376 387 10.1016/j.freeradbiomed.2005.08.044 16443152
    [Google Scholar]
  58. Settembre C. Di Malta C. Polito V.A. Arencibia M.G. Vetrini F. Erdin S. Erdin S.U. Huynh T. Medina D. Colella P. Sardiello M. Rubinsztein D.C. Ballabio A. TFEB links autophagy to lysosomal biogenesis. Science 2011 332 6036 1429 1433 10.1126/science.1204592 21617040
    [Google Scholar]
  59. Wang H.D. Fukuda T. Suzuki T. Hashimoto K. Liou S.Y. Momoi T. Kosaka T. Yamamoto K. Nakanishi H. Differential effects of Bcl-2 overexpression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice. J. Neurosci. Res. 1999 57 1 1 12 10.1002/(SICI)1097‑4547(19990701)57:1<1:AID‑JNR1>3.0.CO;2‑Y 10397630
    [Google Scholar]
  60. Villa-González M. Martín-López G. Pérez-Álvarez M.J. Dysregulation of mTOR signaling after brain ischemia. Int. J. Mol. Sci. 2022 23 5 2814 10.3390/ijms23052814 35269956
    [Google Scholar]
  61. Napolitano G. Esposito A. Choi H. Matarese M. Benedetti V. Di Malta C. Monfregola J. Medina D.L. Lippincott-Schwartz J. Ballabio A. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat. Commun. 2018 9 1 3312 10.1038/s41467‑018‑05862‑6 30120233
    [Google Scholar]
  62. Song Q. Meng B. Xu H. Mao Z. The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases. Transl. Neurodegener. 2020 9 1 17 10.1186/s40035‑020‑00196‑0 32393395
    [Google Scholar]
  63. Liu Y.Y. Zhang T.Y. Xue X. Liu D.M. Zhang H.T. Yuan L.L. Liu Y.L. Yang H.L. Sun S.B. Zhang C. Xu H.S. Wu C.F. Yang J.Y. Pseudoginsenoside‐F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects. CNS Neurosci. Ther. 2017 23 7 567 579 10.1111/cns.12702 28485547
    [Google Scholar]
  64. Wen M. Jin Y. Zhang H. Sun X. Kuai Y. Tan W. Proteomic analysis of rat cerebral cortex in the subacute to long-term phases of focal cerebral ischemia-reperfusion injury. J. Proteome Res. 2019 18 8 3099 3118 10.1021/acs.jproteome.9b00220 31265301
    [Google Scholar]
  65. Kundu S.T. Grzeskowiak C.L. Fradette J.J. Gibson L.A. Rodriguez L.B. Creighton C.J. Scott K.L. Gibbons D.L. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat. Commun. 2018 9 1 2731 10.1038/s41467‑018‑05013‑x 30013069
    [Google Scholar]
  66. Niemeyer C. Matosin N. Kaul D. Philipsen A. Gassen N.C. The role of cathepsins in memory functions and the pathophysiology of psychiatric disorders. Front. Psychiatry 2020 11 718 10.3389/fpsyt.2020.00718 32793006
    [Google Scholar]
  67. Stoka V. Turk V. Turk B. Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res. Rev. 2016 32 22 37 10.1016/j.arr.2016.04.010 27125852
    [Google Scholar]
  68. Lipton P. Lysosomal membrane permeabilization as a key player in brain ischemic cell death: A “lysosomocentric” hypothesis for ischemic brain damage. Transl. Stroke Res. 2013 4 6 672 684 10.1007/s12975‑013‑0301‑2 24323421
    [Google Scholar]
  69. Puissant A. Colosetti P. Robert G. Cassuto J-P. Raynaud S. Auberger P. Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR–ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia 2010 24 1 115 124 10.1038/leu.2009.233 19924144
    [Google Scholar]
  70. Kos J. Mitrović A. Mirković B. The current stage of cathepsin B inhibitors as potential anticancer agents. Future Med. Chem. 2014 6 11 1355 1371 10.4155/fmc.14.73 25163003
    [Google Scholar]
  71. Felbor U. Kessler B. Mothes W. Goebel H.H. Ploegh H.L. Bronson R.T. Olsen B.R. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. USA 2002 99 12 7883 7888 10.1073/pnas.112632299 12048238
    [Google Scholar]
  72. Büth H. Luigi Buttigieg P. Ostafe R. Rehders M. Dannenmann S.R. Schaschke N. Stark H.J. Boukamp P. Brix K. Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes. Eur. J. Cell Biol. 2007 86 11-12 747 761 10.1016/j.ejcb.2007.03.009 17651862
    [Google Scholar]
  73. Seyfried D. Han Y. Zheng Z. Day N. Moin K. Rempel S. Sloane B. Chopp M. Cathepsin B and middle cerebral artery occlusion in the rat. J. Neurosurg. 1997 87 5 716 723 10.3171/jns.1997.87.5.0716 9347980
    [Google Scholar]
  74. Xu M. Yang L. Rong J.G. Ni Y. Gu W.W. Luo Y. Ishidoh K. Katunuma N. Li Z.S. Zhang H.L. Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid‐mitochondrial apoptotic signaling pathway. Glia 2014 62 6 855 880 10.1002/glia.22645 24616078
    [Google Scholar]
  75. Le D.A. Wu Y. Huang Z. Matsushita K. Plesnila N. Augustinack J.C. Hyman B.T. Yuan J. Kuida K. Flavell R.A. Moskowitz M.A. Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. USA 2002 99 23 15188 15193 10.1073/pnas.232473399 12415117
    [Google Scholar]
  76. Yin X.M. Luo Y. Cao G. Bai L. Pei W. Kuharsky D.K. Chen J. Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia. J. Biol. Chem. 2002 277 44 42074 42081 10.1074/jbc.M204991200 12200426
    [Google Scholar]
  77. Yuan D. Liu C. Hu B. Dysfunction of membrane trafficking Leads to ischemia-reperfusion injury after transient cerebral ischemia. Transl. Stroke Res. 2018 9 3 215 222 10.1007/s12975‑017‑0572‑0 29022237
    [Google Scholar]
  78. Sugawara T. Fujimura M. Noshita N. Kim G.W. Saito A. Hayashi T. Narasimhan P. Maier C.M. Chan P.H. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 2004 1 1 17 25 10.1602/neurorx.1.1.17 15717004
    [Google Scholar]
  79. Ley K. Laudanna C. Cybulsky M.I. Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007 7 9 678 689 10.1038/nri2156 17717539
    [Google Scholar]
  80. Jin J. Mu Y. Zhang H. Sturmlechner I. Wang C. Jadhav R.R. Xia Q. Weyand C.M. Goronzy J.J. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging. Nat. Aging 2023 3 5 600 616 10.1038/s43587‑023‑00399‑w 37118554
    [Google Scholar]
  81. Slee E.A. Harte M.T. Kluck R.M. Wolf B.B. Casiano C.A. Newmeyer D.D. Wang H.G. Reed J.C. Nicholson D.W. Alnemri E.S. Green D.R. Martin S.J. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999 144 2 281 292 10.1083/jcb.144.2.281 9922454
    [Google Scholar]
  82. Sairanen T. Szepesi R. Karjalainen-Lindsberg M.L. Saksi J. Paetau A. Lindsberg P.J. Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke. Acta Neuropathol. 2009 118 4 541 552 10.1007/s00401‑009‑0559‑3 19529948
    [Google Scholar]
  83. Yamashima T. Oikawa S. The role of lysosomal rupture in neuronal death. Prog. Neurobiol. 2009 89 4 343 358 10.1016/j.pneurobio.2009.09.003 19772886
    [Google Scholar]
  84. Yamashima T. Kohda Y. Tsuchiya K. Ueno T. Yamashita J. Yoshioka T. Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA‐074: A novel strategy for neuroprotection based on ‘calpain–cathepsin hypothesis’. Eur. J. Neurosci. 1998 10 5 1723 1733 10.1046/j.1460‑9568.1998.00184.x 9751144
    [Google Scholar]
  85. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 2000 62 3 273 295 10.1016/S0301‑0082(00)00006‑X 10840150
    [Google Scholar]
  86. Wang J.Y. Xia Q. Chu K.T. Pan J. Sun L.N. Zeng B. Zhu Y.J. Wang Q. Wang K. Luo B.Y. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: A widely used inhibitor of autophagy. J. Neuropathol. Exp. Neurol. 2011 70 4 314 322 10.1097/NEN.0b013e31821352bd 21412169
    [Google Scholar]
  87. Tsubokawa T. Solaroglu I. Yatsushige H. Cahill J. Yata K. Zhang J.H. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 2006 37 7 1888 1894 10.1161/01.STR.0000227259.15506.24 16763180
    [Google Scholar]
  88. Zhou D. Li M. Hu H. Chen Y. Yang Y. Zhong J. Liu L. Huoxue rongluo tablet reduces matrix metalloproteinase-9 expression in infarcted brain tissue. Neural Regen. Res. 2013 8 34 3216 3224 [PMID: 25206642
    [Google Scholar]
  89. Hu X. Bao Y. Li M. Zhang W. Chen C. The role of ferroptosis and its mechanism in ischemic stroke. Exp. Neurol. 2024 372 114630 10.1016/j.expneurol.2023.114630 38056585
    [Google Scholar]
  90. Liu J. Pang S.Y. Zhou S.Y. He Q.Y. Zhao R.Y. Qu Y. Yang Y. Guo Z.N. Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway. Redox Biol. 2024 76 103342 10.1016/j.redox.2024.103342 39265498
    [Google Scholar]
  91. Jin W. Zhao J. Yang E. Wang Y. Wang Q. Wu Y. Tong F. Tan Y. Zhou J. Kang C. Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics 2022 12 7 3196 3216 10.7150/thno.71029 35547748
    [Google Scholar]
  92. Li C. Sun G. Chen B. Xu L. Ye Y. He J. Bao Z. Zhao P. Miao Z. Zhao L. Hu J. You Y. Liu N. Chao H. Ji J. Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke. Pharmacol. Res. 2021 174 105933 10.1016/j.phrs.2021.105933 34634471
    [Google Scholar]
  93. Dong X. Zhang T. Zhang C. Shang W. Zhang Y. Zhang X. Traditional chinese herbal medicines for the treatment of ischemic stroke in China. Ageing Res. Rev. 2025 110 102803 10.1016/j.arr.2025.102803 40516828
    [Google Scholar]
  94. García-Yébenes I. Sobrado M. Moraga A. Zarruk J.G. Romera V.G. Pradillo J.M. Perez de la Ossa N. Moro M.A. Dávalos A. Lizasoain I. Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion. Neurochem. Int. 2012 61 8 1364 1369 10.1016/j.neuint.2012.09.014 23036361
    [Google Scholar]
  95. Xu W. Lv H. Xue Y. Shi X. Fu S. Li X. Wang C. Zhao D. Han D. Fraxinellone-mediated targeting of cathepsin B leakage from lysosomes induces ferroptosis in fibroblasts to inhibit hypertrophic scar formation. Biol. Direct 2025 20 1 17 10.1186/s13062‑025‑00610‑5 39905520
    [Google Scholar]
  96. Li C. Sun S. Zhuang Y. Luo Z. Ji G. Liu Z. CTSB nuclear translocation facilitates DNA damage and lysosomal stress to promote retinoblastoma cell death. Mol. Biotechnol. 2024 66 9 2583 2594 10.1007/s12033‑023‑01042‑0 38159170
    [Google Scholar]
  97. Xu J. Ding Y. Shi C. Yuan F. Sheng X. Liu Y. Xie Y. Lu H. Duan C. Hu J. Jiang L. Identification of cathepsin B as a therapeutic target for ferroptosis of macrophage after spinal cord injury. Aging Dis. 2024 15 1 421 443 10.14336/AD.2023.0509 37307830
    [Google Scholar]
  98. Nagakannan P. Islam M.I. Conrad M. Eftekharpour E. Cathepsin B is an executioner of ferroptosis. Biochim. Biophys. Acta Mol. Cell Res. 2021 1868 3 118928 10.1016/j.bbamcr.2020.118928 33340545
    [Google Scholar]
  99. Zuo X. Hou Q. Jin J. Zhan L. Li X. Sun W. Lin K. Xu E. Inhibition of cathepsin B alleviates secondary degeneration in] ipsilateral thalamus after focal cerebral infarction in adult rats. J. Neuropathol. Exp. Neurol. 2016 75 9 816 826 10.1093/jnen/nlw054 27371711
    [Google Scholar]
  100. Ni J. Wu Z. Peterts C. Yamamoto K. Qing H. Nakanishi H. The critical role of proteolytic relay through cathepsins B and E in the phenotypic change of microglia/macrophage. J. Neurosci. 2015 35 36 12488 12501 10.1523/JNEUROSCI.1599‑15.2015 26354916
    [Google Scholar]
  101. Yang C. Gong S. Chen X. Wang M. Zhang L. Zhang L. Hu C. Analgecine regulates microglia polarization in ischemic stroke by inhibiting NF-κB through the TLR4 MyD88 pathway. Int. Immunopharmacol. 2021 99 107930 10.1016/j.intimp.2021.107930 34229178
    [Google Scholar]
  102. Zhang M. Guo B. Zhang X. Han D. Lv L. Yan X. Su C. Chai D. Zhao N. Yan X. Hu S. IFP35, a novel DAMP, aggravates neuroinflammation following acute ischemic stroke via TLR4/NF-κB/NLRP3 signaling. J. Neuroinflammation 2025 22 1 164 10.1186/s12974‑025‑03492‑6 40563086
    [Google Scholar]
  103. Fann D.Y.W. Lim Y.A. Cheng Y.L. Lok K.Z. Chunduri P. Baik S.H. Drummond G.R. Dheen S.T. Sobey C.G. Jo D.G. Chen C.L.H. Arumugam T.V. Evidence that NF-κB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol. Neurobiol. 2018 55 2 1082 1096 10.1007/s12035‑017‑0394‑9 28092085
    [Google Scholar]
  104. Alishahi M. Farzaneh M. Ghaedrahmati F. Nejabatdoust A. Sarkaki A. Khoshnam S.E. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target. Int. J. Stroke 2019 14 6 574 591 10.1177/1747493019841242 30940045
    [Google Scholar]
  105. Zhao H. Wang M. Gao Y. Wu X. Xiao H. Yang D. He F. Lv J. Xie D. Wang Q. Liu W. Luo J. Yang Z. Zhang C. Cheng J. Zhao Y. Vespakinin-M, a natural peptide from vespa magnifica, promotes functional recovery in stroke mice. Commun. Biol. 2022 5 1 74 10.1038/s42003‑022‑03024‑5 35058552
    [Google Scholar]
  106. Nakanishi H. Cathepsin regulation on microglial function. Biochim. Biophys. Acta. Proteins Proteomics 2020 1868 9 140465 10.1016/j.bbapap.2020.140465 32526473
    [Google Scholar]
  107. Liu R. Liao X.Y. Pan M.X. Tang J.C. Chen S.F. Zhang Y. Lu P.X. Lu L.J. Zou Y.Y. Qin X.P. Bu L.H. Wan Q. Glycine exhibits neuroprotective effects in ischemic stroke in rats through the inhibition of M1 microglial polarization via the NF-κB p65/Hif-1α signaling pathway. J. Immunol. 2019 202 6 1704 1714 10.4049/jimmunol.1801166 30710045
    [Google Scholar]
  108. Huang P. Cao Q. Xu M. Dong X.P. Lysosomal ATP transporter SLC17A9 controls cell viability via regulating cathepsin D. Cells 2022 11 5 887 10.3390/cells11050887 35269509
    [Google Scholar]
  109. Qiao L. Hamamichi S. Caldwell K.A. Caldwell G.A. Yacoubian T.A. Wilson S. Xie Z.L. Speake L.D. Parks R. Crabtree D. Liang Q. Crimmins S. Schneider L. Uchiyama Y. Iwatsubo T. Zhou Y. Peng L. Lu Y. Standaert D.G. Walls K.C. Shacka J.J. Roth K.A. Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 2008 1 1 17 10.1186/1756‑6606‑1‑17 19021916
    [Google Scholar]
  110. Guo D.Z. Xiao L. Liu Y.J. Shen C. Lou H.F. Lv Y. Pan S.Y. Cathepsin D deficiency delays central nervous system myelination by inhibiting proteolipid protein trafficking from late endosome/lysosome to plasma membrane. Exp. Mol. Med. 2018 50 3 e457 10.1038/emm.2017.291 29546879
    [Google Scholar]
  111. Chen J.H. Kuo H.C. Lee K.F. Tsai T.H. Global proteomic analysis of brain tissues in transient ischemia brain damage in rats. Int. J. Mol. Sci. 2015 16 6 11873 11891 10.3390/ijms160611873 26016499
    [Google Scholar]
  112. Tanida I. Ueno T. Kominami E. LC3 and autophagy. Methods Mol. Biol. 2008 445 77 88 10.1007/978‑1‑59745‑157‑4_4 18425443
    [Google Scholar]
  113. Mahemuti Y. Kadeer K. Su R. Abula A. Aili Y. Maimaiti A. Abulaiti S. Maimaitituerxun M. Miao T. Jiang S. Axier A. Aisha M. Wang Y. Cheng X. TSPO exacerbates acute cerebral ischemia/reperfusion injury by inducing autophagy dysfunction. Exp. Neurol. 2023 369 114542 10.1016/j.expneurol.2023.114542 37717810
    [Google Scholar]
  114. Conus S. Perozzo R. Reinheckel T. Peters C. Scapozza L. Yousefi S. Simon H.U. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 2008 205 3 685 698 10.1084/jem.20072152 18299403
    [Google Scholar]
  115. Liu J. Yang L. Tian H. Ma Q. Cathepsin D is involved in the oxygen and glucose deprivation/reperfusion-induced apoptosis of astrocytes. Int. J. Mol. Med. 2016 38 4 1257 1263 10.3892/ijmm.2016.2709 27573911
    [Google Scholar]
  116. Nakanishi H. Tsukuba T. Kondou T. Tanaka T. Yamamoto K. Transient forebrain ischemia induces increased expression and specific localization of cathepsins E and D in rat hippocampus and neostriatum. Exp. Neurol. 1993 121 2 215 223 10.1006/exnr.1993.1088 8339772
    [Google Scholar]
  117. Zhang N. Gao P. Yin B. Li J. Wu T. Kuang Y. Wu W. Li J. Cathepsin L promotes secretory IgA response by participating in antigen presentation pathways during Mycoplasma Hyopneumoniae infection. PLoS One 2019 14 4 e0215408 10.1371/journal.pone.0215408 30986254
    [Google Scholar]
  118. Vizovišek M. Fonović M. Turk B. Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond. Matrix Biol. 2019 75-76 141 159 10.1016/j.matbio.2018.01.024 29409929
    [Google Scholar]
  119. Gu Y.H. Kanazawa M. Hung S.Y. Wang X. Fukuda S. Koziol J.A. Zoppo G.J. Cathepsin L acutely alters microvessel integrity within the neurovascular unit during focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2015 35 11 1888 1900 10.1038/jcbfm.2015.170 26198177
    [Google Scholar]
  120. Karamanos N.K. Theocharis A.D. Piperigkou Z. Manou D. Passi A. Skandalis S.S. Vynios D.H. Orian-Rousseau V. Ricard-Blum S. Schmelzer C.E.H. Duca L. Durbeej M. Afratis N.A. Troeberg L. Franchi M. Masola V. Onisto M. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021 288 24 6850 6912 10.1111/febs.15776 33605520
    [Google Scholar]
  121. Fukuda S. Fini C.A. Mabuchi T. Koziol J.A. Eggleston L.L. del Zoppo G.J. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 2004 35 4 998 1004 10.1161/01.STR.0000119383.76447.05 15001799
    [Google Scholar]
  122. Zhou X.Y. Luo Y. Zhu Y.M. Liu Z.H. Kent T.A. Rong J.G. Li W. Qiao S.G. Li M. Ni Y. Ishidoh K. Zhang H.L. Inhibition of autophagy blocks cathepsins–tBid–mitochondrial apoptotic signaling pathway via stabilization of lysosomal membrane in ischemic astrocytes. Cell Death Dis. 2017 8 2 e2618 10.1038/cddis.2017.34 28206988
    [Google Scholar]
  123. Dutta P. Courties G. Wei Y. Leuschner F. Gorbatov R. Robbins C.S. Iwamoto Y. Thompson B. Carlson A.L. Heidt T. Majmudar M.D. Lasitschka F. Etzrodt M. Waterman P. Waring M.T. Chicoine A.T. van der Laan A.M. Niessen H.W.M. Piek J.J. Rubin B.B. Butany J. Stone J.R. Katus H.A. Murphy S.A. Morrow D.A. Sabatine M.S. Vinegoni C. Moskowitz M.A. Pittet M.J. Libby P. Lin C.P. Swirski F.K. Weissleder R. Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012 487 7407 325 329 10.1038/nature11260 22763456
    [Google Scholar]
  124. Faraday N. Schunke K. Saleem S. Fu J. Wang B. Zhang J. Morrell C. Dore S. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS One 2013 8 8 e71447 10.1371/journal.pone.0071447 23940756
    [Google Scholar]
  125. Schunke K.J. Koehler R.C. Faraday N. Abstract W P236: Role of leukocyte cathepsin G in an atherothrombotic stroke model. Stroke 2015 46 46 10.1161/str.46.suppl_1.wp236
    [Google Scholar]
  126. Song H.Y. Chung J.I. Jalin A.M.A. Ju C. Pahk K. Joung C. Lee S. Jin S. Kim B.S. Lee K.S. Ryu J.M. Kim W.K. The quinazoline Otaplimastat (SP-8203) reduces the hemorrhagic transformation and mortality aggravated after delayed rtPA-induced thrombolysis in cerebral ischemia. Int. J. Mol. Sci. 2022 23 3 1403 10.3390/ijms23031403 35163322
    [Google Scholar]
  127. Zhao R. He X.W. Shi Y.H. Liu Y.S. Liu F.D. Hu Y. Zhuang M.T. Feng X.Y. Zhao L. Zhao B.Q. Liu H.Q. Shi G.P. Liu J.R. Cathepsin K knockout exacerbates haemorrhagic transformation induced by recombinant tissue plasminogen activator after focal cerebral ischaemia in mice. Cell. Mol. Neurobiol. 2019 39 6 823 831 10.1007/s10571‑019‑00682‑8 31065924
    [Google Scholar]
  128. Bobek L.A. Levine M.J. Cystatins-inhibitors of cysteine proteinases. Crit. Rev. Oral Biol. Med. 1992 3 4 307 332 10.1177/10454411920030040101 1391414
    [Google Scholar]
  129. Gui Y. Kim Y. Brenna S. Wilmes M. Zaghen G. Goulbourne C.N. Kuchenbecker-Pöls L. Siebels B. Voß H. Gocke A. Schlüter H. Schweizer M. Altmeppen H.C. Magnus T. Levy E. Puig B. Cystatin C loaded in brain-derived extracellular vesicles rescues synapses after ischemic insult in vitro and in vivo. Cell. Mol. Life Sci. 2024 81 1 224 10.1007/s00018‑024‑05266‑4 38769196
    [Google Scholar]
  130. Hanada K. Tamai M. Yamagishi M. Ohmura S. Sawada J. Tanaka I. Isolation and characterization of E–64, a new thiol protease inhibitor. Agric. Biol. Chem. 1978 42 3 523 528 10.1080/00021369.1978.10863014
    [Google Scholar]
  131. Towatari T. Nikawa T. Murata M. Yokoo C. Tamai M. Hanada K. Katunuma N. Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo. FEBS Lett. 1991 280 2 311 315 10.1016/0014‑5793(91)80319‑X 2013329
    [Google Scholar]
  132. Buttle D.J. Murata M. Knight C.G. Barrett A.J. CA074 methyl ester: A proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 1992 299 2 377 380 10.1016/0003‑9861(92)90290‑D 1444478
    [Google Scholar]
  133. Jia H. Zhang B. Han X. Yu P. Xiong B. Liu T. Shan L. Yang X. Hou Q. Inhibition of cathepsin B ameliorates murine cognitive dysfunction and neuronal damage in ischemic stroke by inhibiting mitochondrial apoptosis and Drp1-mediated mitochondrial fission. Mol. Neurobiol. 2025 62 12688 12704 10.1007/s12035‑025‑05094‑y 40447852
    [Google Scholar]
  134. Seyfried D.M. Veyna R. Han Y. Li K. Tang N. Betts R.L. Weinsheimer S. Chopp M. Anagli J. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res. 2001 901 1-2 94 101 10.1016/S0006‑8993(01)02289‑2 11368955
    [Google Scholar]
  135. Yang D. Han Y. Zhang J. Ding C. Anagli J. Seyfried D.M. Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor. J. Neurosurg. 2011 114 4 1110 1116 10.3171/2010.6.JNS091856 20672894
    [Google Scholar]
  136. Klöhn M. Burkard T. Janzen J. Haase J.A. Gömer A. Fu R. Ssebyatika G. Nocke M.K. Brown R.J.P. Krey T. Dao Thi V.L. Kinast V. Brüggemann Y. Todt D. Steinmann E. Targeting cellular cathepsins inhibits hepatitis E virus entry. Hepatology 2024 80 5 1239 1251 10.1097/HEP.0000000000000912 38728662
    [Google Scholar]
  137. Mellott D.M. Tseng C.T. Drelich A. Fajtová P. Chenna B.C. Kostomiris D.H. Hsu J. Zhu J. Taylor Z.W. Kocurek K.I. Tat V. Katzfuss A. Li L. Giardini M.A. Skinner D. Hirata K. Yoon M.C. Beck S. Carlin A.F. Clark A.E. Beretta L. Maneval D. Hook V. Frueh F. Hurst B.L. Wang H. Raushel F.M. O’Donoghue A.J. de Siqueira-Neto J.L. Meek T.D. McKerrow J.H. A clinical-stage cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells. ACS Chem. Biol. 2021 16 4 642 650 10.1021/acschembio.0c00875 33787221
    [Google Scholar]
  138. Ahsan A. Zheng Y. Ma S. Liu M. Cao M. Li Y. Zheng W. Zhou X. Xin M. Hu W. Chen Z. Zhang X. Tomatidine protects against ischemic neuronal injury by improving lysosomal function. Eur. J. Pharmacol. 2020 882 173280 10.1016/j.ejphar.2020.173280 32580039
    [Google Scholar]
  139. Benýšek J. Buša M. Rubešová P. Fanfrlík J. Lepšík M. Brynda J. Matoušková Z. Bartz U. Horn M. Gütschow M. Mareš M. Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: Structural analysis of binding mode to mature and zymogen-like enzymes. J. Enzyme Inhib. Med. Chem. 2022 37 1 515 526 10.1080/14756366.2021.2024527 35144520
    [Google Scholar]
  140. Petruzzella A. Bruand M. Santamaria-Martínez A. Katanayeva N. Reymond L. Wehrle S. Georgeon S. Inel D. van Dalen F.J. Viertl D. Lau K. Pojer F. Schottelius M. Zoete V. Verdoes M. Arber C. Correia B.E. Oricchio E. Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins. Nat. Chem. Biol. 2024 20 9 1188 1198 10.1038/s41589‑024‑01627‑z 38811854
    [Google Scholar]
  141. Breuer C. Küppers J. Schulz-Fincke A.C. Heilos A. Lemke C. Spiwoková P. Schmitz J. Cremer L. Frigolé-Vivas M. Lülsdorff M. Mertens M.D. Wichterle F. Apeltauer M. Horn M. Gilberg E. Furtmann N. Bajorath J. Bartz U. Engels B. Mareš M. Gütschow M. Redirecting the peptide cleavage causes protease inactivation. Angew. Chem. Int. Ed. 2025 64 31 e202506832 10.1002/anie.202506832 40394881
    [Google Scholar]
  142. Businaro R. Tagliani A. Buttari B. Profumo E. Ippoliti F. Di Cristofano C. Capoano R. Salvati B. Riganò R. Cellular and molecular players in the atherosclerotic plaque progression. Ann. N. Y. Acad. Sci. 2012 1262 1 134 141 10.1111/j.1749‑6632.2012.06600.x 22823445
    [Google Scholar]
  143. Platt M.O. Ankeny R.F. Shi G.P. Weiss D. Vega J.D. Taylor W.R. Jo H. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 2007 292 3 H1479 H1486 10.1152/ajpheart.00954.2006 17098827
    [Google Scholar]
  144. Sukhova G.K. Shi G.P. Simon D.I. Chapman H.A. Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 1998 102 3 576 583 10.1172/JCI181 9691094
    [Google Scholar]
  145. Abd-Elrahman I. Meir K. Kosuge H. Ben-Nun Y. Weiss Sadan T. Rubinstein C. Samet Y. McConnell M.V. Blum G. Characterizing cathepsin activity and macrophage subtypes in excised human carotid plaques. Stroke 2016 47 4 1101 1108 10.1161/STROKEAHA.115.011573 26941255
    [Google Scholar]
  146. Wang H. Jiang H. Cheng X.W. Cathepsin S are involved in human carotid atherosclerotic disease progression, mainly by mediating phagosomes: Bioinformatics and in vivo and vitro experiments. PeerJ 2022 10 e12846 10.7717/peerj.12846 35186462
    [Google Scholar]
  147. Li W. Kornmark L. Jonasson L. Forssell C. Yuan X.M. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 2009 202 1 92 102 10.1016/j.atherosclerosis.2008.03.027 18495127
    [Google Scholar]
  148. Ma L. Wu S. Gusdon A.M. Chen H. Hu H. Paz A.S. Aronowski J. Savarraj J.P. Kitagawa R.S. Choi H.A. Ren X.S. Cathepsin L and acute ischemic stroke: A mini-review. Front. Stroke 2022 1 1050536 10.3389/fstro.2022.1050536
    [Google Scholar]
  149. Walter E.R.H. Cooper S.M. Boyle J.J. Long N.J. Enzyme-activated probes in optical imaging: A focus on atherosclerosis. Dalton Trans. 2021 50 41 14486 14497 10.1039/D1DT02198B 34605500
    [Google Scholar]
  150. Ma Y. Shang J. Liu L. Li M. Xu X. Cao H. Xu L. Sun W. Song G. Zhang X.B. Rational design of a double-locked photoacoustic probe for precise in vivo imaging of cathepsin B in atherosclerotic plaques. J. Am. Chem. Soc. 2023 145 32 17881 17891 10.1021/jacs.3c04981 37531186
    [Google Scholar]
  151. Li W. Dalen H. Eaton J.W. Yuan X.M. Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 2001 21 7 1124 1130 10.1161/hq0701.092145 11451740
    [Google Scholar]
  152. Shi G.P. Sukhova G.K. Grubb A. Ducharme A. Rhode L.H. Lee R.T. Ridker P.M. Libby P. Chapman H.A. Cystatin C] deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 1999 104 9 1191 1197 10.1172/JCI7709 10545518
    [Google Scholar]
  153. Luo F. Luo J.Y. Liu F. Qiu Y.J. Tian X.X. Zeng L. Zhang Z.R. Li X.M. Yang Y.N. Coronary artery calcium and cystatin C for risk stratification of MACCEs and all‐cause death in symptomatic patients. Clin. Cardiol. 2023 46 2 195 203 10.1002/clc.23959 36484372
    [Google Scholar]
  154. Song H. Zhou H. Qu Z. Hou J. Chen W. Cai W. Cheng Q. Chuang D.Y. Chen S. Li S. Li J. Cheng J. Greenlief C.M. Lu Y. Simonyi A. Sun G.Y. Wu C. Cui J. Gu Z. From analysis of ischemic mouse brain proteome to identification of human serum clusterin as a potential biomarker for severity of acute ischemic stroke. Transl. Stroke Res. 2019 10 5 546 556 10.1007/s12975‑018‑0675‑2 30465328
    [Google Scholar]
  155. Yan X. Chen H. Shang X.L. Association between serum cystatin C level and post‐stroke cognitive impairment in patients with acute mild ischemic stroke. Brain Behav. 2022 12 3 e2519 10.1002/brb3.2519 35148465
    [Google Scholar]
  156. Xiaoqian L. Chunyu Y. Hongmei D. Xiuping M. Fengning G. Dan C. Youmin F. The study of serum C-reactive protein,] serum cystatin C, and carbohydrate antigen 125 in patients with acute ischemic stroke. Cell. Mol. Biol. 2022 68 5 89 95 10.14715/cmb/2022.68.5.12 36029510
    [Google Scholar]
  157. Ding Y. Liu L. Chen Z. Li H. Pan Y. Wang J. Meng X. Lin J. Jing J. Xie X. Xiang X. Wang Y. Serum cystatin C predicts stroke clinical outcomes at 1 year independent of renal function. Front. Neurol. 2021 12 676872 10.3389/fneur.2021.676872 34456843
    [Google Scholar]
  158. Winovich D.T. Longstreth W.T. Arnold A.M. Varadhan R. Zeki Al Hazzouri A. Cushman M. Newman A.B. Odden M.C. Factors associated with ischemic stroke survival and recovery in older adults. Stroke 2017 48 7 1818 1826 10.1161/STROKEAHA.117.016726 28526765
    [Google Scholar]
  159. Hou L. Chen X. Zhu C. A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes. Front. Public Health 2023 11 1049738 10.3389/fpubh.2023.1049738 37841730
    [Google Scholar]
  160. Chen K. Huang G. Cai C. Yan C. Zhang F. Yao M. Nuchkrua T. Ma J. Xu H. Higher cystatin C level increases the risk of delayed cerebral ischemia after endovascular treatment of] aneurysmal subarachnoid hemorrhage: A case–control study. Neurosurg. Rev. 2022 45 3 2407 2415 10.1007/s10143‑022‑01765‑9 35247129
    [Google Scholar]
  161. Chang Z. Zou H. Xie Z. Deng B. Que R. Huang Z. Weng G. Wu Z. Pan Y. Wang Y. Li M. Xie H. Zhu S. Xiong L. C.T. Mok V.; Jin, K.; Yenari, M.A.; Wei, X.; Wang, Q. Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case–control study. Eur. J. Neurol. 2021 28 4 1265 1274 10.1111/ene.14663 33277774
    [Google Scholar]
  162. Li H. Zhang B. Huang Z. Wu H. Qin B. Zhou L. Lu Z. Qin F. Prognostic significance of serum cystatin C in acute brainstem infarctions patients. Rev. Neurol. 2024 180 7 642 649 10.1016/j.neurol.2024.01.007 38553271
    [Google Scholar]
/content/journals/cn/10.2174/011570159X399036251124052750
Loading
Cathepsins in Ischemic Stroke: Unveiling Neuropharmacological Roles and Therapeutic Potential
Bentham Science Publishers ; https://doi.org/10.2174/011570159X399036251124052750
/content/journals/cn/10.2174/011570159X399036251124052750
/content/journals/cn/10.2174/011570159X399036251124052750
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: neuroinflammation ; microglia ; cathepsins ; therapeutic strategy ; Ischemic stroke ; autophagy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test